Showing 5221-5230 of 6036 results for "".
- Rayner to Lower Carbon Footprint by More Than 800 Tons Over 5 Yearshttps://modernod.com/news/rayner-to-lower-carbon-footprint-by-more-than-800-tonnes-over-5-years/2478056/Rayner announced that changes to their manufacturing and packaging procedures will reduce CO2 greenhouse gas emissions by more than 800 tons over the next 5 years. The reduced CO2 greenhouse gas emissions are the result of three dedicated waste-reducing projects:
- Pfizer, BioNTech’s mRNA-Based COVID-19 Vaccine Shows Promise in Second Studyhttps://modernod.com/news/pfizer-biontechs-mrna-based-covid-19-vaccine-shows-promise-in-second-study/2478049/Pfizer and BioNTech announced that the most advanced of four COVID-19 vaccine candidates from their BNT162 mRNA-based vaccine program demonstrated the ability to elicit high SARS-CoV-2 neutralising titers after the second dose in an ongoing phase 1/2 study in Germany. The results, which were publ
- GenSight Biologics Reports Final REALITY Study Confirms Poor Spontaneous Recovery for LHON Patients with ND4 mutationhttps://modernod.com/news/gensight-biologics-reports-final-reality-study-confirms-poor-spontaneous-recovery-for-lhon-patients-with-nd4-mutation/2478050/GenSight Biologics reported results from the final analysis of the REALITY natural history study, which reaffirm the poor prognosis for the vast majority of Leber Hereditary Optic Neuropathy (LHON) patients with vision loss due to a mutated ND4mitochondrial gene. “The REALITY findings bols
- AffronEYE Saffron Extract Aims to Reduce Risks of Long-Term Blue-Light Induced Eye Injuryhttps://modernod.com/news/affroneye-saffron-extract-aims-to-reduce-risks-of-long-term-blue-light-induced-eye-injury/2478051/In a digital era, the increasing dependence on screens and technology particularly among gamers is prolonging exposure to blue light. Madrid, Spain-based nutraceutical company Pharmactive Biotech Products offers its proprietary affronEYE saffron ingredient, a fast
- Glaucoma Study Findings Emphasize Need for Regular Eye Checkshttps://modernod.com/news/glaucoma-study-findings-emphasize-need-for-regular-eye-checks/2478048/People with early-stage glaucoma see the contrast of visible objects in a very similar way to people without the condition, a new study has shown. Research by the University of Bradford (UK) demonstrated that the brain compensates for the changes in the eye caused by glaucoma, when looking
- Oxford-AstraZeneca Covid Vaccine Study Shows Dual Immune Actionhttps://modernod.com/news/oxford-astrazeneca-covid-vaccine-study-shows-dual-immune-action/2478042/A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen, according to a Bloomberg
- National Vision Announces Special Cash Bonus to Front-Line Associates and Doctorshttps://modernod.com/news/national-vision-announces-special-cash-bonus-to-front-line-associates-and-doctors/2478032/National Vision Holdings announced plans to grant a special cash bonus to front-line associates and doctors. A one-time $250 bonus will be given to all patient-facing and customer-facing associates and the company’s network of doctors in recognition of their hard work and dedication toward
- Topcon Acquires Henson Perimeter Businesshttps://modernod.com/news/topcon-acquires-henson-perimeter-business/2478033/Topcon Healthcare announced that it has acquired the Henson line of perimetry products, including the Henson 9000 and 7000, from Elektron Eye Technology (EET) of Cambridge, UK. Terms of the deal were not disclosed. The acquisitions include the transfer of a number of EET staff to To
- Tarsus Pharmaceuticals Announces Appointment of New COO and CFOhttps://modernod.com/news/tarsus-pharmaceuticals-announces-appointment-of-new-coo-and-cfo/2478029/Tarsus Pharmaceuticals announced the appointment of two pharmaceutical veterans to its executive leadership team: Sesha Neervannan, PhD, to the position of Chief Operating Officer (COO), and Leo Greenstein to the position of Chief Financial Officer (CFO). As part of its leadership, Sesha and Leo
- COVID-19 Has Flipped the Physician Job Search to a Seller’s Market, Recruiters Sayhttps://modernod.com/news/covid-19-has-flipped-the-physician-job-search-to-a-sellers-market-recruiters-say/2478020/Job opportunities for doctors have dried up quite a bit in wake of the COVID-19 pandemic, at least in the short term, according to an annual report from physician search firm Merritt Hawkins, according to a FierceHealthcare